|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016011,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0220825,
umls-concept:C0302350,
umls-concept:C0522523,
umls-concept:C0597357,
umls-concept:C1416485,
umls-concept:C1522318,
umls-concept:C1948041,
umls-concept:C2605669
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-26
|
|
pubmed:abstractText |
This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab. We expected to obtain same results as with ReoPro in improving ischemic cardiac complications in high-risk patients who were about to undergo percutaneous coronary intervention (PCI).
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-10341274,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-10627437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-10861081,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-10938172,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-11230835,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-11231437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-11419425,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-11419426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-11738323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-12383588,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-16105872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-2264841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-2969312,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-2991335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-7508826,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-7908357,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-8121459,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-8598866,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9164315,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9164316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9182212,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9315530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9599103,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9599104,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9641689,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9705684,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9860783,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18581587-9878986
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0513-5796
|
|
pubmed:author |
pubmed-author:AhnYoungkeunY,
pubmed-author:ChoiDonghoonD,
pubmed-author:HongMyeong-KiMK,
pubmed-author:JangYangsooY,
pubmed-author:JeongMyung HoMH,
pubmed-author:KimJu HanJH,
pubmed-author:KimWeonW,
pubmed-author:KimYoung-HakYH,
pubmed-author:KoYoung-GukYG,
pubmed-author:MoonJae-YounJY,
pubmed-author:ParkSeong-WookSW,
pubmed-author:ParkSeung-JungSJ,
pubmed-author:ParkSunghaS
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
389-99
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18581587-Acute Coronary Syndrome,
pubmed-meshheading:18581587-Adult,
pubmed-meshheading:18581587-Aged,
pubmed-meshheading:18581587-Aged, 80 and over,
pubmed-meshheading:18581587-Angioplasty, Balloon, Coronary,
pubmed-meshheading:18581587-Antibodies, Monoclonal,
pubmed-meshheading:18581587-Drugs, Investigational,
pubmed-meshheading:18581587-Female,
pubmed-meshheading:18581587-Humans,
pubmed-meshheading:18581587-Immunoglobulin Fab Fragments,
pubmed-meshheading:18581587-Male,
pubmed-meshheading:18581587-Middle Aged,
pubmed-meshheading:18581587-Myocardial Ischemia,
pubmed-meshheading:18581587-Platelet Aggregation Inhibitors,
pubmed-meshheading:18581587-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:18581587-Prospective Studies,
pubmed-meshheading:18581587-Risk Factors,
pubmed-meshheading:18581587-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.
|
|
pubmed:affiliation |
The Heart Center of Chonnam National University Hospital, Gwangju, Korea.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
